Sun Pharma Advanced Research Co (NSE:SPARC) Scaled Net Operating Assets : N/A (As of Sep. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Sun Pharma Advanced Research Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sun Pharma Advanced Research Co's operating assets for the quarter that ended in Sep. 2024 was ₹0.0 Mil. Sun Pharma Advanced Research Co's operating liabilities for the quarter that ended in Sep. 2024 was ₹0.0 Mil. Sun Pharma Advanced Research Co's Total Assets for the quarter that ended in Jun. 2024 was ₹0.0 Mil. Therefore, Sun Pharma Advanced Research Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was N/A.

Sun Pharma Advanced Research Co Scaled Net Operating Assets Historical Data

The historical data trend for Sun Pharma Advanced Research Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharma Advanced Research Co Scaled Net Operating Assets Chart

Sun Pharma Advanced Research Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.10

0.19

0.43

0.45

0.04

Sun Pharma Advanced Research Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Scaled Net Operating Assets	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Sun Pharma Advanced Research Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharma Advanced Research Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sun Pharma Advanced Research Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharma Advanced Research Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Sun Pharma Advanced Research Co's Scaled Net Operating Assets falls into.

Sun Pharma Advanced Research Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sun Pharma Advanced Research Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2024 )
=	(Operating Assets (A: Mar. 2024 )	-	Operating Liabilities (A: Mar. 2024 ))	/	Total Assets (A: Mar. 2023 )
=	(3579.114	-	3281.358)	/	8301.261
=	0.04

where

	Operating Assets		(A: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	5150.422	-	1571.308
=	3579.114

	Operating Liabilities		(A: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3892.868	-	106.609	-	504.901
=	3281.358

Sun Pharma Advanced Research Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2024 )
=	(Operating Assets (Q: Sep. 2024 )	-	Operating Liabilities (Q: Sep. 2024 ))	/	Total Assets (Q: Jun. 2024 )
=	(0	-	0)	/	0
=	N/A

where

	Operating Assets		(Q: Sep. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0	-	0
=	0

	Operating Liabilities		(Q: Sep. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0	-	0	-	0
=	0

Sun Pharma Advanced Research Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Sun Pharma Advanced Research Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharma Advanced Research Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharma Advanced Research Co Ltd (NSE:SPARC) » Definitions » Scaled Net Operating Assets

Traded in Other Exchanges

532872:India

Address

Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093

Website

https://www.sparc.life

Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in othe4r countries.

Sun Pharma Advanced Research Co Headlines

No Headlines